-
Mashup Score: 2La Fundación Jiménez Díaz de Madrid, Premio Top Value Global - 1 month(s) ago
Los hospitales Rey Juan Carlos de Móstoles, General de Villalba en Collado Villalba e Infanta Elena de Valdemoro también han sido galardonados
Source: www.larazon.esCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study - 8 month(s) ago
In the single-arm, open-label, multicenter, phase 2 PILOT study, second-line treatment with the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel) in patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) for whom hematopoietic stem cell transplantation (HSCT) was not intended resulted in high response rates, durable responses, and a safety profile consistent with previous reports. Here, we analyzed changes in health-related quality of life (HRQOL) in patients who received liso-cel in PILOT. Patients received liso-cel, an autologous, CD19-directed, 4-1BB CAR T-cell product administered at equal target doses of CD8+ and CD4+ CAR+ T cells, for a total target dose of 100 × 10⁶ CAR+ T cells. HRQOL, a secondary endpoint of PILOT, was assessed as prespecified using 3 patient-reported outcome instruments (EORTC QLQ-C30; FACT-LymS; EQ-5D-5L). Evaluable datasets for the EORTC QLQ-C30, FACT-LymS, EQ-5D-5L health utility index, and EQ-5D visual ana
Source: haematologica.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
La Fundación Jiménez Díaz, Rey Juan Carlos, Infanta Elena y General de Villalba han mostrado su evaluación de resultados
Source: Redacción MédicaCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Introduction Different validated questionnaires to assess quality of life (QoL) exist and are used in clinical trials for patients with hematological malignanci
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma - 1 year(s) ago
Key Points. Axi-cel showed clinically meaningful improvements in QoL in 2L LBCL over SOC at days 100 and 150.There was a trend toward faster recovery to baselin
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Homepage | PCORI - 2 year(s) ago
The PCORI Strategic Plan A Bold Vision for Addressing Healthcare Challenges Generating Evidence to Achieve More Efficient, Effective, and Equitable Health Care and Improve Health for All Learn More Our Impact and Evidence You Can Use …
Source: www.pcori.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Purpose Older survivors of leukemia and lymphoma often experience long-term effects of chemotherapy. We described common concerns related to their cancer and treatment in older survivors of leukemia and non-Hodgkin lymphoma (NHL) and assessed correlates of these concerns. Methods We utilized data from the Women’s Health Initiative (WHI) Life and Longevity After Cancer (LILAC) study that recruited…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe - 2 year(s) ago
The increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship.
Source: Annals of OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
La Fundación Jiménez Díaz (@Hospital_FJD)de Madrid, Premio Top Value Global #VBHC https://t.co/dmiSeripwJ